Entering text into the input field will update the search result below

ORFG, ENZ, PHM, EEE, FBC- Stock Reports! from Stock-PR.com

Jan. 13, 2011 2:18 PM ET
Lynnai profile picture
Lynnai's Blog
13 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

________________________________________

Orofino Gold Corp. (ORFG.PK)

Orofino Gold Corp. has several Gold development properties in Colombia, a current hot spot of gold production in the world markets.

ORFG is please to announce that the Board Of Directors have appointed Mr. Ning Shi Long as Chairman of the Board and Executive Director.

Mr. Ary Fernando Pernett Marque has been appointed as the new President/CEO & Executive Director of Orofino Gold Corp. See full resume on ORFG's website.

Mr. Pernett will be responsible for all affairs of ORFG in Colombia. Mr. Pernett has 30 years of experience working in the Colombian Mining sector and will over the near term choose his new development team to assist in the development of the company’s Senderos de Oro gold camp in the Sur de Bolivar Colombia.

ORFG and Mr. Pernett will continue to work with Contexto Legal of Medellin and Bogota, ORFG ’s legal counsel as well as Discovery Consultants, (The Qualified 43-101 team) Canada, as they have in the past. The new team will now aggressively pursue other known Gold occurrences in the companies Senderos de Oro Gold Camp while the development team works to improve production at La Azul Mine.

The Board of Director’s have accepted resignation of John T. Martin, former Managing Director of the Company. His resignation is effective immediately. ORFG wish him well and success in future endeavors.

http://pennyomega.com/img/enz.jpg

Enzo Biochem (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. Founded in 1976, Enzo Biochem has concentrated on the development of enabling technologies in the areas of gene regulation and gene modification. Many of Enzo Biochem’s technologies are applicable to the biomedical and pharmaceutical research markets, and the Company is further using these technologies as a platform for entry into the clinical diagnostics market. Today, Enzo technologies and products are recognized as the key tools in non-radioactive gene labeling used by researchers worldwide. Additionally, Enzo’s work in gene analysis has led to development of a number of significant therapeutic candidates for the treatment of viral and immunological based disorders, several of which are in various phases of human clinical trials. In the course of Enzo Biochem’s extensive research and development activities, they have built a significant patent position consisting of numerous pioneer patents and applications that encompass core technologies.

Enzo Biochem, Inc. reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

“We are pleased to report that our program instituted this quarter aimed at making Enzo more efficient and designed to produce more effective use of our assets is beginning to show results, as demonstrated by improved performance, ” said Barry Weiner, President. “While we are in the early stages of this comprehensive program, the results experienced to date are very encouraging.”

“Moreover, in the first quarter, we achieved several milestones. We submitted Colon Sentry, a unique assay for risk-stratification of colon cancer occurrence, to the New York State Department of Health for approval. In addition, we began enrolling the first patients in our clinical trial of Optiquel™, our candidate therapeutic for the treatment of autoimmune uveitis. We also continued to roll out proprietary products and systems designed to aid in drug development,” he added.

Enzo Clinical Labs (”Lab”) benefited in the quarter from increased market share and service volume increases in connection with its being named a participating provider for Empire BlueCross BlueShield in the metropolitan New York area.

Enzo Life Sciences’ profitability for the quarter improved due to benefits from the plan instituted in July to integrate functions and rationalize workforce levels.

PulteGroup, Inc. (NYSE:PHM) announced that it will release its fourth quarter 2010 financial results before the market opens on Friday, February 4, 2011. The Company will hold a conference call to discuss fourth quarter results that same day at 8:30 a.m. (ET), Friday, February 4, 2011. A live audio webcast of the call will be available on PulteGroup’s website at www.pultegroupinc.com.
Pultegroup, Inc., through its subsidiaries, engages in homebuilding and financial services businesses primarily in the United States.

Evergreen Energy, Inc. (NYSEA:EEE) issued the following open letter to the company’s shareholders from its recently appointed Executive Chairman of the Board of Directors, Ilyas Khan: It has been a week since I became Chairman of Evergreen Energy Inc., and the purpose of this letter is to reach out and say hello to shareholders, and to communicate some basic objectives. As some of you may be aware, I am very familiar with Evergreen and the K-Fuel® technology, having watched the company closely for a number of years. I am well versed on Evergreen’s technologies and its history both the accomplishments as well as the challenges. As the company’s new Executive Chairman, I am now fully dedicated to guiding Evergreen to reach its potential, which I believe is significant.

Flagstar Bancorp Inc. (NYSE:FBC) released instructions for its fourth quarter 2010 Analyst / Investor Conference Call. The purpose of the call is to discuss the Company's fourth quarter 2010 earnings that will be released before the market opens on January 26, 2011. Representing the Company on the call will be Joseph P. Campanelli, Chairman and CEO, and Paul D. Borja, CFO. The conference call will take place the same day, on Wednesday, January 26, 2011, from 11 a.m. to 12 noon (Eastern). To join, please call (866) 294-1212 toll free or (702) 696-4911 and use passcode: 36800260. Please call at least 10 minutes before the call is scheduled to begin. A replay will be available for five business days by calling (800) 642-1687 toll free or (706) 645-9291 using the passcode: 36800260. The conference call will also be available as a live audiocast on the Investor Relations section of www.flagstar.com.
Flagstar Bancorp, Inc. operates as the holding company for Flagstar Bank, FSB that offers consumer and commercial financial products and services to individuals, and small and middle market businesses in Michigan, Indiana, and Georgia.

**************************************************************

"POTESTAS PELCARDSTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg

________________________________________

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.